Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China · Delayed Price · Currency is CNY 20.50
+0.39 (1.94%)
Jun 18, 2026, 3:04 PM CST
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 9.79 billion as of June 18, 2026. Its market cap has increased by 38.70% in one year.
Market Cap
9.79B
Enterprise Value
9.77B
Revenue
203.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.50
Market Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 9.79B, an increase of 194.36%. That is a compound annual growth rate of 7.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 9.79B | -24.96% |
| Dec 31, 2025 | 13.05B | 268.69% |
| Dec 31, 2024 | 3.54B | -27.07% |
| Dec 29, 2023 | 4.85B | -24.38% |
| Dec 30, 2022 | 6.42B | -22.12% |
| Dec 31, 2021 | 8.24B | 94.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 11.22B |
| Chengzhi | 10.86B |
| Inner Mongolia Furui Medical Science | 10.84B |
| Pacific Shuanglin Bio-pharmacy | 10.82B |
| HitGen | 10.59B |
| Jiangxi Fushine Pharmaceutical | 9.81B |
| Hualan Biological Vaccine | 9.75B |
| InventisBio | 9.67B |